List of Excipients in API canagliflozin and metformin hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing canagliflozin and metformin hydrochloride
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Janssen Pharmaceuticals Inc | INVOKAMET | canagliflozin and metformin hydrochloride | 50458-540 | CELLULOSE, MICROCRYSTALLINE | 2029-02-26 |
| Janssen Pharmaceuticals Inc | INVOKAMET | canagliflozin and metformin hydrochloride | 50458-540 | CROSCARMELLOSE SODIUM | 2029-02-26 |
| Janssen Pharmaceuticals Inc | INVOKAMET | canagliflozin and metformin hydrochloride | 50458-540 | HYPROMELLOSE | 2029-02-26 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for canagliflozin and metformin hydrochloride
Excipient focus: CELLULOSE, MICROCRYSTALLINE
canagliflozin and metformin hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Janssen Pharmaceuticals Inc | canagliflozin and metformin hydrochloride | 50458-540 |
| Bryant Ranch Prepack | canagliflozin and metformin hydrochloride | 63629-8260 |
| >Company | >Ingredient | >NDC |
canagliflozin and metformin hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
canagliflozin and metformin hydrochloride drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Janssen Pharmaceuticals Inc | canagliflozin and metformin hydrochloride | 50458-540 |
| Bryant Ranch Prepack | canagliflozin and metformin hydrochloride | 63629-8260 |
| >Company | >Ingredient | >NDC |
canagliflozin and metformin hydrochloride drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
canagliflozin and metformin hydrochloride drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | canagliflozin and metformin hydrochloride | 63629-8260 |
| >Company | >Ingredient | >NDC |
canagliflozin and metformin hydrochloride drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Janssen Pharmaceuticals Inc | canagliflozin and metformin hydrochloride | 50458-540 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
canagliflozin and metformin hydrochloride drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | canagliflozin and metformin hydrochloride | 63629-8260 |
| >Company | >Ingredient | >NDC |
canagliflozin and metformin hydrochloride drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Janssen Pharmaceuticals Inc | canagliflozin and metformin hydrochloride | 50458-540 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
canagliflozin and metformin hydrochloride drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Janssen Pharmaceuticals Inc | canagliflozin and metformin hydrochloride | 50458-540 |
| Bryant Ranch Prepack | canagliflozin and metformin hydrochloride | 63629-8260 |
| >Company | >Ingredient | >NDC |
canagliflozin and metformin hydrochloride drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
canagliflozin and metformin hydrochloride drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Janssen Pharmaceuticals Inc | canagliflozin and metformin hydrochloride | 50458-540 |
| Bryant Ranch Prepack | canagliflozin and metformin hydrochloride | 63629-8260 |
| >Company | >Ingredient | >NDC |
canagliflozin and metformin hydrochloride drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
canagliflozin and metformin hydrochloride drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Janssen Pharmaceuticals Inc | canagliflozin and metformin hydrochloride | 50458-540 |
| Bryant Ranch Prepack | canagliflozin and metformin hydrochloride | 63629-8260 |
| >Company | >Ingredient | >NDC |
canagliflozin and metformin hydrochloride drug variants not containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
canagliflozin and metformin hydrochloride drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Janssen Pharmaceuticals Inc | canagliflozin and metformin hydrochloride | 50458-540 |
| Bryant Ranch Prepack | canagliflozin and metformin hydrochloride | 63629-8260 |
| >Company | >Ingredient | >NDC |
canagliflozin and metformin hydrochloride drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
canagliflozin and metformin hydrochloride drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Janssen Pharmaceuticals Inc | canagliflozin and metformin hydrochloride | 50458-540 |
| Bryant Ranch Prepack | canagliflozin and metformin hydrochloride | 63629-8260 |
| >Company | >Ingredient | >NDC |
canagliflozin and metformin hydrochloride drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
canagliflozin and metformin hydrochloride drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Janssen Pharmaceuticals Inc | canagliflozin and metformin hydrochloride | 50458-540 |
| Bryant Ranch Prepack | canagliflozin and metformin hydrochloride | 63629-8260 |
| >Company | >Ingredient | >NDC |
canagliflozin and metformin hydrochloride drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
canagliflozin and metformin hydrochloride drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Janssen Pharmaceuticals Inc | canagliflozin and metformin hydrochloride | 50458-540 |
| Bryant Ranch Prepack | canagliflozin and metformin hydrochloride | 63629-8260 |
| >Company | >Ingredient | >NDC |
canagliflozin and metformin hydrochloride drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
